| 1 |
New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation
Nava Zisapel · British Journal of Pharmacology
Open access |
10 Jan 2018 |
868 |
| 2 |
Improvement of sleep quality in elderly people by controlled-release melatonin
Doron Garfinkel, Moshe Laudon, Dina Nof et al. · The Lancet
|
Aug 1995 |
478 |
| 3 |
Melatonin Replacement Therapy of Elderly Insomniacs
Iris Haimov, Peretz Lavie, Moshe Laudon et al. · SLEEP
|
Sep 1995 |
348 |
| 4 |
Sleep disorders and melatonin rhythms in elderly people
Iris Haimov, Moshe Laudon, Nava Zisapel et al. · BMJ
Open access |
16 Jul 1994 |
316 |
| 5 |
Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder
Paul Gringras, Tali Nir, John Breddy et al. · Journal of the American Academy of Child & Adolescent Psychiatry
Open access |
19 Sep 2017 |
312 |
| 6 |
Improving Postoperative Immune Status and Resistance to Cancer Metastasis
Yael Goldfarb, Liat Sorski, Marganit Benish et al. · Annals of Surgery
|
26 Feb 2011 |
267 |
| 7 |
Prolonged‐release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects
Patrick Lemoine, Tali Nir, Moshe Laudon et al. · Journal of Sleep Research
|
21 Nov 2007 |
263 |
| 8 |
Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes
Alan G. Wade, Ian Ford, Gordon M. Crawford et al. · Current Medical Research and Opinion
|
14 Sep 2007 |
237 |
| 9 |
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
Alan G. Wade, Ian Ford, Gordon M. Crawford et al. · BMC Medicine
Open access |
16 Aug 2010 |
180 |
| 10 |
Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder
Athanasios Maras, Carmen M Schroder, Beth Ann Malow et al. · Journal of Child and Adolescent Psychopharmacology
Open access |
22 Aug 2018 |
179 |
| 11 |
Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder
Beth Ann Malow, Robert L. Findling, Carmen M Schroder et al. · Journal of the American Academy of Child & Adolescent Psychiatry
Open access |
23 Jan 2020 |
176 |
| 12 |
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial
Moshe Laudon, Alan G. Wade, Mildred V. Farmer et al. · Clinical Interventions in Aging
Open access |
Jun 2014 |
174 |
| 13 |
Melatonin Reduces Night Blood Pressure in Patients with Nocturnal Hypertension
Ehud Grossman, Moshe Laudon, Rıdvan Yalçin et al. · The American Journal of Medicine
|
24 Sep 2006 |
168 |
| 14 |
Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy
Damien Léger, Moshe Laudon, Nava Zisapel · The American Journal of Medicine
|
2004 |
159 |
| 15 |
Clinical trials of controlled‐release melatonin in children with sleep–wake cycle disorders
James E. Jan, Don Hamilton, Nadine Seward et al. · Journal of Pineal Research
|
May 2000 |
153 |
| 16 |
Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders
Moshe Laudon, Anat Frydman‐Marom · International Journal of Molecular Sciences
Open access |
9 Sep 2014 |
149 |
| 17 |
Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials
Moshe Laudon, Grossman, Nava Zisapel · Vascular Health and Risk Management
ReviewOpen access |
Sep 2011 |
149 |
| 18 |
Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of Life
Carmen M Schroder, Beth Ann Malow, Athanasios Maras et al. · Journal of Autism and Developmental Disorders
Open access |
11 May 2019 |
139 |
| 19 |
The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia
R. Luthringer, Muriel Muzet, Nava Zisapel et al. · International Clinical Psychopharmacology
|
10 Aug 2009 |
138 |
| 20 |
Effects of prolonged‐release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers
Sarah Otmani, A. Demazières, Corinne Staner et al. · Human Psychopharmacology Clinical and Experimental
|
2 Sep 2008 |
131 |
| 21 |
Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study
Nava Zisapel, Garfinkel, V Zorin et al. · Diabetes Metabolic Syndrome and Obesity
Open access |
Aug 2011 |
129 |
| 22 |
Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response
Alan G. Wade, Gordon M. Crawford, Ian Ford et al. · Current Medical Research and Opinion
|
24 Nov 2010 |
129 |
| 23 |
Determination of the minimal clinically significant difference on a patient visual analog sleep quality scale
Nava Zisapel, Tali Nir · Journal of Sleep Research
|
24 Nov 2003 |
123 |
| 24 |
NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats
Meihua She, Xiaojian Deng, Zhenyu Guo et al. · Pharmacological Research
|
27 Jan 2009 |
117 |
| 25 |
A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease
Pingping He, Xin-Ping Ouyang, Shouhong Zhou et al. · Hormones and Behavior
|
4 May 2013 |
96 |
| 26 |
Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder
Sébastien Lalanne, Claire Fougerou‐Leurent, George M. Anderson et al. · International Journal of Molecular Sciences
Open access |
2 Feb 2021 |
91 |
| 27 |
In vivo suppression of NK cell cytotoxicity by stress and surgery: Glucocorticoids have a minor role compared to catecholamines and prostaglandins
Ella Rosenne, Liat Sorski, Lee Shaashua et al. · Brain Behavior and Immunity
Open access |
12 Dec 2013 |
88 |
| 28 |
Cross‐cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients
Ricardo Tarrasch, Moshe Laudon, Nava Zisapel · Human Psychopharmacology Clinical and Experimental
|
Dec 2003 |
87 |
| 29 |
Serum levels of sex hormones and corticosterone throughout 4- and 5-day estrous cycles in Fischer 344 rats and their simulation in ovariectomized females
Sara Haim, Guy Shakhar, Ella Rossene et al. · Journal of Endocrinological Investigation
|
Oct 2003 |
81 |
| 30 |
Massage Therapy by Mothers Enhances the Adjustment of Circadian Rhythms to the Nocturnal Period in Full-Term Infants
Sari Goldstein Ferber, Moshe Laudon, Jacob Kuint et al. · Journal of Developmental & Behavioral Pediatrics
|
Dec 2002 |
75 |
| 31 |
Drugs for insomnia
Nava Zisapel · Expert Opinion on Emerging Drugs
|
11 Jun 2012 |
70 |
| 32 |
Effect of controlled-release melatonin on sleep quality, mood, and quality of life in subjects with seasonal or weather-associated changes in mood and behaviour
Sami Leppämäki, Timo Partonen, Olli Vakkuri et al. · European Neuropsychopharmacology
|
May 2003 |
70 |
| 33 |
Prolonged-Release Melatonin for Children With Neurodevelopmental Disorders
Hélène De Leersnyder, Nava Zisapel, Moshe Laudon · Pediatric Neurology
|
Jul 2011 |
69 |
| 34 |
Cardiovascular effects of melatonin receptor agonists
Ludovít Paulis, Fedor Šimko, Moshe Laudon · Expert Opinion on Investigational Drugs
|
23 Aug 2012 |
66 |
| 35 |
Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs
Doron Garfinkel, Moshe Laudon, Nava Zisapel · Archives of Gerontology and Geriatrics
|
Mar 1997 |
64 |
| 36 |
Subjective assessment of the effects of CNS‐active drugs on sleep by the Leeds sleep evaluation questionnaire: a review
Nava Zisapel, Moshe Laudon · Human Psychopharmacology Clinical and Experimental
|
2003 |
63 |
| 37 |
Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models
Shaowen Tian, Moshe Laudon, Li Han et al. · Acta Pharmacologica Sinica
Open access |
28 Jun 2010 |
62 |
| 38 |
Melatonin Production in Healthy Infants: Evidence for Seasonal Variations
Yakov Sivan, Moshe Laudon, Rivi Tauman et al. · Pediatric Research
|
2001 |
61 |
| 39 |
CD44 Splice Variants as Potential Players in Alzheimer’s Disease Pathology
Elhanan Pinner, Yaron Gruper, Micha Ben Zimra et al. · Journal of Alzheimer s Disease
|
25 May 2017 |
56 |
| 40 |
Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal
Nava Zisapel, Lemoine, Doron Garfinkel et al. · Therapeutics and Clinical Risk Management
Open access |
Jul 2011 |
54 |
| 41 |
Preliminary Observations on APOE ϵ4 Allele and Progression of Disability in Multiple Sclerosis
Joab Chapman, Constanatin Sylantiev, Puiu Nisipeanu et al. · Archives of Neurology
|
Dec 1999 |
54 |
| 42 |
Melatonin production in infants
Riva Tauman, Nava Zisapel, Moshe Laudon et al. · Pediatric Neurology
|
May 2002 |
46 |
| 43 |
Melatonin receptors in diabetes: A potential new therapeutical target?
Meihua She, Moshe Laudon, Weidong Yin · European Journal of Pharmacology
|
24 Aug 2014 |
45 |
| 44 |
Effects of prolonged‐release melatonin and zolpidem on postural stability in older adults
Sarah Otmani, DEBORAH A. METZGER, Nathalie Guichard et al. · Human Psychopharmacology Clinical and Experimental
|
20 Feb 2012 |
45 |
| 45 |
High NK cell activity in recurrent miscarriage: what are we really measuring?
Keren Shakhar · Human Reproduction
|
9 May 2006 |
43 |
| 46 |
Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials
Amnon Katz, Lemoine, Wade et al. · Integrated Blood Pressure Control
Open access |
2012 |
40 |
| 47 |
Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models
Izaskun Buendía, Vanessa Gómez‐Rangel, Laura González‐Lafuente et al. · Neuropharmacology
|
16 Jul 2015 |
40 |
| 48 |
The relationship between melatonin and cortisol rhythms: clinical implications of melatonin therapy
Nava Zisapel, Ricardo Tarrasch, Moshe Laudon · Drug Development Research
|
Jul 2005 |
39 |
| 49 |
Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin
Göran Hajak, Kathrin Lemme, Nava Zisapel · International Clinical Psychopharmacology
Open access |
23 Jul 2014 |
39 |
| 50 |
Putative melatonin receptors in benign human prostate tissue.
Moshe Laudon, Eli Gilad, Haim Matzkin et al. · The Journal of Clinical Endocrinology & Metabolism
Open access |
Apr 1996 |
39 |